Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes

• Published in: PloS one Vol. 10; no. 7; p. e0133672
• Main Authors: Thomsen, Stine B, Gjesing, Anette P, Rathcke, Camilla N, Ekstrøm, Claus T, Eiberg, Hans, Hansen, Torben, Pedersen, Oluf, Vestergaard, Henrik
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 21.07.2015; Public Library of Science (PLoS)
• Subjects: Adipokines - blood; Adult; Anthropometry; Arthritis; Biomarkers - blood; Cardiovascular disease; Cardiovascular diseases; Cell adhesion & migration; Chitinase; Chitinase-3-Like Protein 1; Comorbidity; Coronary vessels; Denmark; Diabetes; Diabetes Complications - diagnosis; Diabetes mellitus; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - diagnosis; Diagnosis; Dyslipidemia; Dyslipidemias - metabolism; Family relations; Fasting; Female; Genetic Predisposition to Disease; Genetics; Glucose; Glucose tolerance; Glucose Tolerance Test; Glycoproteins; Health risks; Health sciences; Heritability; Hip; Homeostasis; Humans; Immune system; Inflammation; Insulin; Insulin Resistance; Intravenous administration; Lectins - blood; Male; Metabolic disorders; Metabolism; Middle Aged; Obesity; Obesity - complications; Obesity - metabolism; Polygenic inheritance; Population; Quality; Research design; Risk Factors; Sensitivity; Serum levels; Triglycerides; Triglycerides - blood; Type 2 diabetes; Waist-Hip Ratio; Weight control
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0133672

Circulating levels of the inflammatory marker YKL-40 are elevated in cardiovascular disease and obesity-related type 2 diabetes (T2D), and serum YKL-40 levels are related to elements of dyslipidaemia. We aimed to investigate the associations between serum YKL-40 and obesity-related traits in a Danish sample of non-diabetic relatives to T2D patients and, furthermore, to estimate the heritability of YKL-40. 324 non-diabetic individuals with family relation to a T2D patient were included in the study. The participants underwent oral- and intravenous glucose tolerance tests for estimation of glucose tolerance and surrogate measures of insulin sensitivity. Anthropometric measures were retrieved and biochemical measures of the plasma lipid profile and serum YKL-40 levels were obtained. Association-analyses between serum YKL-40 and obesity-related traits and estimates of the narrow sense heritability of YKL-40 were based on a polygenic variance component model. Fasting serum levels of YKL-40 were positively associated with waist-hip-ratio (p<0.001) and fasting plasma triglyceride levels (p<0.001). None of the insulin sensitivity indexes were significantly associated with YKL-40. According to the AE model, the familiality-estimate h2 of YKL-40 was 0.45 (SE 0.13). When the ACE-model was applied, the heritability-estimate h2 of YKL-40 did not reach statistical significance. Our results suggest a role of serum YKL-40 in obesity-related low grade inflammation, but do not indicate that YKL-40 is directly involved in the development of T2D.